We provide you with 20 years of free, institutional-grade data for SRRK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SRRK. Explore the full financial landscape of SRRK stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$1,584,510
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Qatanani Mo | Sale | -3,353 | $30.67 | $102,846 | 2025-09-24 |
| Qatanani Mo | Sale | -3,178 | $33.52 | $106,527 | 2025-09-17 |
| Peng Katie | Sale | -1,006 | $32.48 | $32,671 | 2025-09-17 |
| Parlavecchio Caryn | Sale | -2,178 | $31.17 | $67,880 | 2025-08-19 |
| FLIER JEFFREY S. | Sale | -11,136 | $40.02 | $445,688 | 2025-07-18 |
| Qatanani Mo | Sale | -24,066 | $34.44 | $828,898 | 2025-07-10 |
| FLIER JEFFREY S. | Sale | -11,136 | $33.21 | $369,818 | 2025-06-25 |
| FLIER JEFFREY S. | Sale | -20,316 | $32.16 | $653,304 | 2025-06-25 |
| FLIER JEFFREY S. | Derivatives Exercise | 20,316 | 2025-06-25 | ||
| Ho Junlin | Sale | -7,442 | $32 | $238,154 | 2025-06-17 |
| Parlavecchio Caryn | Sale | -6,186 | $32 | $197,961 | 2025-06-17 |
| Peng Katie | Sale | -3,031 | $31.96 | $96,857 | 2025-06-17 |
| Qatanani Mo | Sale | -3,668 | $32 | $117,381 | 2025-06-17 |
| Ho Junlin | Grant, award...etc | 8,571 | 2025-06-11 | ||
| Reed Joshua | Sale | -5,400 | $29.68 | $160,282 | 2025-05-30 |
| Vaishnaw Akshay | Sale | -6,750 | $29.63 | $200,000 | 2025-05-30 |
| Brudnick Richard | Sale | -6,075 | $29.63 | $180,010 | 2025-05-30 |
| Burow Kristina | Sale | -5,400 | $29.24 | $157,906 | 2025-05-30 |
| FLIER JEFFREY S. | Sale | -6,075 | $29.23 | $177,583 | 2025-05-30 |
| Gilman Michael | Sale | -3,375 | $29.22 | $98,616 | 2025-05-30 |
| Peng Katie | Grant, award...etc | 7,632 | 2025-05-23 | ||
| Gilman Michael | Grant, award...etc | 7,632 | 2025-05-23 | ||
| FLIER JEFFREY S. | Grant, award...etc | 7,632 | 2025-05-23 | ||
| Reed Joshua | Grant, award...etc | 7,632 | 2025-05-23 | ||
| AKKARAJU SRINIVAS | Grant, award...etc | 7,632 | 2025-05-23 | ||
| Burow Kristina | Grant, award...etc | 7,632 | 2025-05-23 | ||
| Brudnick Richard | Grant, award...etc | 7,632 | 2025-05-23 | ||
| Sacco Tracey | Sale | -5,000 | $32.81 | $164,075 | 2025-04-29 |
| Sacco Tracey | Derivatives Exercise | 5,000 | 2025-04-29 | ||
| Woods Keith | Grant, award...etc | 600,000 | 2025-04-29 | ||
| Vaishnaw Akshay | Grant, award...etc | 600,000 | 2025-04-29 | ||
| Sinha Vikas | Grant, award...etc | 600,000 | 2025-04-29 | ||
| Hallal David | Grant, award...etc | 1,500,000 | 2025-04-29 | ||
| Sacco Tracey | Sale | -6,500 | $33.7 | $219,074 | 2025-03-25 |
| Sacco Tracey | Derivatives Exercise | 5,000 | 2025-03-25 | ||
| Moore Erin | Sale | -13,564 | $33.12 | $449,237 | 2025-03-25 |
| Moore Erin | Derivatives Exercise | 13,564 | 2025-03-25 | ||
| Moore Erin | Initial | 2025-03-21 | |||
| Peng Katie | Sale | -1,006 | $34.42 | $34,627 | 2025-03-19 |
| Sacco Tracey | Grant, award...etc | 27,855 | 2025-03-12 | ||
| Ho Junlin | Grant, award...etc | 32,145 | 2025-03-12 | ||
| Backstrom Jay T. | Grant, award...etc | 113,570 | 2025-03-12 | ||
| Qatanani Mo | Grant, award...etc | 32,145 | 2025-03-12 | ||
| Parlavecchio Caryn | Grant, award...etc | 23,570 | 2025-03-12 | ||
| Marantz Jing L. | Grant, award...etc | 34,285 | 2025-03-12 | ||
| Myles Edward H | Sale | -142,292 | $35.82 | $5,096,899 | 2025-03-12 |
| Myles Edward H | Derivatives Exercise | 112,897 | 2025-03-12 | ||
| Backstrom Jay T. | Sale | -18,372 | $36.83 | $676,622 | 2025-02-20 |
| Parlavecchio Caryn | Sale | -5,296 | $36.83 | $195,046 | 2025-02-20 |
| Myles Edward H | Sale | -7,809 | $36.83 | $287,598 | 2025-02-20 |
| Qatanani Mo | Derivatives Exercise | 48,308 | 2025-02-20 | ||
| Qatanani Mo | Sale | -72,645 | $36.83 | $2,675,443 | 2025-02-20 |
| Ho Junlin | Sale | -5,742 | $36.83 | $211,472 | 2025-02-20 |
| Parlavecchio Caryn | Sale | -6,434 | $44.2 | $284,365 | 2025-01-21 |
| Ho Junlin | Sale | -9,039 | $44.2 | $399,498 | 2025-01-21 |
| Myles Edward H | Sale | -12,539 | $44.2 | $554,189 | 2025-01-21 |
| Marantz Jing L. | Sale | -5,655 | $44.2 | $249,935 | 2025-01-21 |
| Backstrom Jay T. | Sale | -22,308 | $44.2 | $985,951 | 2025-01-21 |
| Sacco Tracey | Sale | -3,890 | $44.2 | $171,927 | 2025-01-21 |
| Qatanani Mo | Sale | -7,347 | $44.2 | $324,717 | 2025-01-21 |
| Invus Public Equities, L.P. | Sale | -1,600,000 | $41.65 | $66,640,000 | 2024-12-12 |
| Invus Public Equities, L.P. | Sale | -409,433 | $37.63 | $15,407,414 | 2024-11-27 |
| Marantz Jing L. | Sale | -8,520 | $30.01 | $255,687 | 2024-11-26 |
| Marantz Jing L. | Derivatives Exercise | 8,520 | 2024-11-26 | ||
| Marantz Jing L. | Sale | -2,105 | $30 | $63,158 | 2024-11-13 |
| Marantz Jing L. | Derivatives Exercise | 2,105 | 2024-11-13 | ||
| Myles Edward H | Sale | -37,187 | $34.9 | $1,297,659 | 2024-10-10 |
| Myles Edward H | Derivatives Exercise | 37,187 | 2024-10-10 | ||
| Marantz Jing L. | Sale | -109,375 | $25.59 | $2,798,742 | 2024-10-07 |
| Marantz Jing L. | Derivatives Exercise | 109,375 | 2024-10-07 | ||
| Sacco Tracey | Sale | -30,000 | $25.58 | $767,400 | 2024-10-07 |
| Sacco Tracey | Derivatives Exercise | 30,000 | 2024-10-07 | ||
| Myles Edward H | Sale | -206,240 | $25.61 | $5,281,806 | 2024-10-07 |
| Myles Edward H | Derivatives Exercise | -206,240 | 2024-10-07 | ||
| AKKARAJU SRINIVAS | Sale | -1,175,713 | $27.5 | $32,332,108 | 2024-10-07 |
| Qatanani Mo | Sale | -1,936 | $8.58 | $16,611 | 2024-09-19 |
| Parlavecchio Caryn | Sale | -1,451 | $9.33 | $13,538 | 2024-08-19 |
| Siren, L.L.C. | Initial | 2024-07-29 | |||
| Gilman Michael | Grant, award...etc | 13,500 | 2024-07-01 | ||
| Hallal David | Grant, award...etc | 13,500 | 2024-07-01 | ||
| Brudnick Richard | Grant, award...etc | 13,500 | 2024-07-01 | ||
| AKKARAJU SRINIVAS | Grant, award...etc | 13,500 | 2024-07-01 | ||
| FLIER JEFFREY S. | Grant, award...etc | 13,500 | 2024-07-01 | ||
| Reed Joshua | Grant, award...etc | 13,500 | 2024-07-01 | ||
| Peng Katie | Grant, award...etc | 4,500 | 2024-07-01 | ||
| Burow Kristina | Grant, award...etc | 13,500 | 2024-07-01 | ||
| Vaishnaw Akshay | Grant, award...etc | 13,500 | 2024-07-01 | ||
| Qatanani Mo | Sale | -2,315 | $8.98 | $20,800 | 2024-06-18 |
| Myles Edward H | Sale | -9,458 | $8.98 | $84,978 | 2024-06-18 |
| Ho Junlin | Sale | -4,695 | $8.98 | $42,183 | 2024-06-18 |
| Parlavecchio Caryn | Sale | -4,305 | $8.98 | $38,680 | 2024-06-18 |
| Peng Katie | Grant, award...etc | 26,825 | 2024-04-11 | ||
| Myles Edward H | Sale | -4,744 | $15.74 | $74,686 | 2024-02-21 |
| Backstrom Jay T. | Sale | -11,614 | $15.74 | $182,842 | 2024-02-20 |
| Ho Junlin | Sale | -3,489 | $15.74 | $54,928 | 2024-02-20 |
| Qatanani Mo | Sale | -2,512 | $15.74 | $39,547 | 2024-02-20 |
| Parlavecchio Caryn | Sale | -3,751 | $15.74 | $59,053 | 2024-02-20 |
| Backstrom Jay T. | Grant, award...etc | 214,285 | 2024-02-13 | ||
| Marantz Jing L. | Grant, award...etc | 72,855 | 2024-02-13 | ||
| Sacco Tracey | Grant, award...etc | 49,285 | 2024-02-13 | ||
| Parlavecchio Caryn | Grant, award...etc | 47,145 | 2024-02-13 | ||
| Qatanani Mo | Grant, award...etc | 70,715 | 2024-02-13 | ||
| Ho Junlin | Grant, award...etc | 57,855 | 2024-02-13 | ||
| Myles Edward H | Grant, award...etc | 53,570 | 2024-02-13 | ||
| Qatanani Mo | Sale | -2,002 | $15.93 | $31,889 | 2024-01-18 |
| Myles Edward H | Sale | -6,634 | $15.93 | $105,670 | 2024-01-18 |
| Parlavecchio Caryn | Sale | -2,849 | $15.93 | $45,381 | 2024-01-18 |
| Ho Junlin | Sale | -4,186 | $15.93 | $66,677 | 2024-01-18 |
| Myles Edward H | Sale | -12,459 | $18.82 | $234,425 | 2023-12-29 |
| Myles Edward H | Derivatives Exercise | 12,459 | 2023-12-29 | ||
| Qatanani Mo | Sale | -24,662 | $18.18 | $448,444 | 2023-12-15 |
| Qatanani Mo | Derivatives Exercise | 8,437 | 2023-12-15 | ||
| Myles Edward H | Sale | -24,914 | $17.53 | $436,820 | 2023-12-08 |
| Myles Edward H | Derivatives Exercise | 24,914 | 2023-12-08 |
The information provided in this report about SRRK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Scholar Rock Holding Corporation(NASDAQ:SRRK) 
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, a novel inhibitor of the activation of l...
Website: http://www.scholarrock.com
Founded: 2012
Full Time Employees: 93
Sector: Healthcare
Industry: Biotechnology